AN2 Therapeutics, Inc., (ANTX): Price and Financial Metrics Recent IPO
GET POWR RATINGS... FREE!
ANTX Stock Price Chart Interactive Chart >
ANTX Price/Volume Stats
| Current price | $7.91 | 52-week high | $23.58 |
| Prev. close | $8.14 | 52-week low | $7.43 |
| Day low | $7.81 | Volume | 47,719 |
| Day high | $8.83 | Avg. volume | 79,713 |
| 50-day MA | $13.01 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 153.48M |
AN2 Therapeutics, Inc., (ANTX) Company Bio
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.
ANTX Price Returns
| 1-mo | N/A |
| 3-mo | -47.51% |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...